Impact of Hepatitis B Virus Genotype on Treatment Response in Children With Chronic Hepatitis B

NCT06289725 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2024-03-18

No results posted yet for this study

Summary

The study aimed to evaluate the relationship between hepatitis B virus genotype and treatment response in children with chronic hepatitis B with specific treatment indications. This is a prospective cohort study, with a follow-up period of at least 12 months, conducted at Children's Hospital 1 and City Children's Hospital, Ho Chi Minh City, Vietnam. The patient's blood was taken to be tested for hepatitis B virus genotyping using Sanger sequencing at the Center for Molecular Biomedicine Ho Chi Minh City. The research hypothesis is that genotype is related to treatment response.

Conditions

Interventions

DRUG

antiviral treatment

The patient was treated with antiviral drugs according to the protocol of the Ministry of Health of Vietnam 2019

Sponsors & Collaborators

  • Ly Hoa Anh Minh

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-01-01
Completion
2026-01-01

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06289725 on ClinicalTrials.gov